We are live on ! Find out more
MEDP icon

Medpace

113 hedge funds and large institutions have $335M invested in Medpace in 2018 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

566% more call options, than puts

Call options by funds: $1.58M | Put options by funds: $237K

33% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 30

8% more capital invested

Capital invested by funds: $311M → $335M (+$24M)

4.75% more ownership

Funds ownership: 22.29%27.04% (+4.8%)

3% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 29

0% more funds holding

Funds holding: 113113 (0)

Holders
113
Holders Change
Holders Change %
0%
% of All Funds
2.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
40
Reduced
30
Closed
29
Calls
$1.58M
Puts
$237K
Net Calls
+$1.34M
Net Calls Change
+$1.34M

MEDP Hedge Fund Activity: Q1 2018 in Review

113 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2018, worth a combined $335M — up 7.7% from $311M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new MEDP positions and 29 closed out — a net gain of 1 holder — while 40 added to existing stakes and 30 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $13.4M. The largest seller was Cardinal Capital Management LLC (Connecticut), exiting entirely with an estimated $8.61M sold.

  • 113 institutional investors held Medpace (MEDP) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $335M of Medpace stock for Q1 2018, up 7.7% quarter-over-quarter.
  • 30 funds opened new Medpace positions in Q1 2018 and 29 closed out, a net change of +1 holder.
  • The largest Medpace buyer in Q1 2018 was Acadian Asset Management, an estimated $13.4M added.
  • The largest Medpace seller in Q1 2018 was Cardinal Capital Management LLC (Connecticut), an estimated $8.61M sold.

Based on aggregated 13F filings for Q1 2018.